Tags

Type your tag names separated by a space and hit enter

Is glycemic control of the critically ill cost-effective?
Hosp Pract (1995). 2014 Oct; 42(4):53-8.HP

Abstract

Intensive monitoring of blood glucose levels and treatment of hyperglycemia have been associated with significant improvements in morbidity and mortality in the critically ill. In contrast to the large prospective and observational body of data relating glycemic control and clinical outcomes, the financial impact of glycemic control implementation has not been as well described. This article details data from interventional trials of intensive insulin therapy; investigations that relate dysglycemia to morbidity, particularly intensive care unit (ICU)-acquired infections and increased ICU length of stay; and evaluations of the attributable cost of nosocomial infection in order to construct a sensitivity analysis of the net economic impact of glycemic control. It concludes that glycemic control is associated with positive financial outcomes, even using very conservative assumptions, and provides the reader with an automated spreadsheet to estimate the financial implications of glycemic control using assumptions based on locally derived data.

Authors+Show Affiliations

Director of Critical Care, Stamford Hospital, Clinical Professor of Medicine, Columbia University College of Physicians and Surgeons, Stamford, CT. jkrinsley@stamhealth.org.

Pub Type(s)

Journal Article
Observational Study

Language

eng

PubMed ID

25502129

Citation

Krinsley, James S.. "Is Glycemic Control of the Critically Ill Cost-effective?" Hospital Practice (1995), vol. 42, no. 4, 2014, pp. 53-8.
Krinsley JS. Is glycemic control of the critically ill cost-effective? Hosp Pract (1995). 2014;42(4):53-8.
Krinsley, J. S. (2014). Is glycemic control of the critically ill cost-effective? Hospital Practice (1995), 42(4), 53-8. https://doi.org/10.3810/hp.2014.10.1142
Krinsley JS. Is Glycemic Control of the Critically Ill Cost-effective. Hosp Pract (1995). 2014;42(4):53-8. PubMed PMID: 25502129.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Is glycemic control of the critically ill cost-effective? A1 - Krinsley,James S, PY - 2014/12/16/entrez PY - 2014/12/17/pubmed PY - 2015/1/30/medline SP - 53 EP - 8 JF - Hospital practice (1995) JO - Hosp Pract (1995) VL - 42 IS - 4 N2 - Intensive monitoring of blood glucose levels and treatment of hyperglycemia have been associated with significant improvements in morbidity and mortality in the critically ill. In contrast to the large prospective and observational body of data relating glycemic control and clinical outcomes, the financial impact of glycemic control implementation has not been as well described. This article details data from interventional trials of intensive insulin therapy; investigations that relate dysglycemia to morbidity, particularly intensive care unit (ICU)-acquired infections and increased ICU length of stay; and evaluations of the attributable cost of nosocomial infection in order to construct a sensitivity analysis of the net economic impact of glycemic control. It concludes that glycemic control is associated with positive financial outcomes, even using very conservative assumptions, and provides the reader with an automated spreadsheet to estimate the financial implications of glycemic control using assumptions based on locally derived data. SN - 2154-8331 UR - https://www.unboundmedicine.com/medline/citation/25502129/Is_glycemic_control_of_the_critically_ill_cost_effective L2 - https://medlineplus.gov/hyperglycemia.html DB - PRIME DP - Unbound Medicine ER -